Pilot Study of Reduced Intensity Haematopoietic Stem Cell Transplantation in Patients With Poor Risk Myelodysplastic Syndrome and Acute Myeloid Leukaemia Utilising Conditioning With Fludarabine, Busulphan and Thymoglobulin.

Trial Profile

Pilot Study of Reduced Intensity Haematopoietic Stem Cell Transplantation in Patients With Poor Risk Myelodysplastic Syndrome and Acute Myeloid Leukaemia Utilising Conditioning With Fludarabine, Busulphan and Thymoglobulin.

Discontinued
Phase of Trial: Phase II

Latest Information Update: 31 Jul 2017

At a glance

  • Drugs Antithymocyte globulin (Primary) ; Busulfan; Fludarabine
  • Indications Acute myeloid leukaemia; Graft-versus-host disease; Myelodysplastic syndromes
  • Focus Adverse reactions
  • Most Recent Events

    • 31 Jul 2017 New source identified and integrated (European Clinical Trials Database EudraCT2006-004452-20)
    • 16 Aug 2011 Planned end date changed from 1 Nov 2009 to 1 Jun 2011 as reported by ClinicalTrials.gov.
    • 16 Aug 2011 Status changed from recruiting to discontinued as reported by ClinicalTrials.gov.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top